JPRN-jRCT2031220265进行中（未招募）3 期
A Phase III, multicenter, open-label study to evaluate the efficacy and safety of NRL-1 intranasally administered in Japanese pediatric patients with or at risk for status epilepticus
akagawa Eiji0 个研究点目标入组 15 人开始时间: 2022年8月11日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 6age old 至 < 18age old（—）
- 性别
- All
入选标准
- •Japanese pediatric patients with or at risk for status epilepticus
排除标准
- •Patients who in the opinion of the Investigator or Subinvestigator, previously failed to respond to diazepam injected within 5 minutes after onset of seizures
研究者
相似试验
未知
3 期
Phase III study of intramuscular TAK-816 in healthy infantsJPRN-jRCT2080222404TAKEDA PHARMACEUTICAL COMPANY LTD.30
进行中（未招募）
3 期
A large, multi-clinic study to evaluate contraceptive efficacy and safety of depot medroxyprogesterone acetate (150 mg/ml) injected under the skin every 6 monthsContraception for up to 6 monthsPregnancy and ChildbirthISRCTN62695528Family Health International 360750
进行中（未招募）
1 期
Immunogenicity and safety study of GlaxoSmithKline (GSK) Biologicals? influenza vaccine when administered in children who previously participated in study 115345Healthy volunteers (Immunization against influenza A and B in children aged 18 to 47 months)MedDRA version: 14.1Level: LLTClassification code 10022001Term: Influenza (epidemic)System Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: LLTClassification code 10022003Term: Influenza B virus infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: PTClassification code 10022000Term: InfluenzaSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: LLTClassification code 10022002Term: Influenza A virus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2012-001230-34-ESGlaxoSmithKline S.A.470
进行中（未招募）
1 期
Immunogenicity and safety study of GlaxoSmithKline (GSK) Biologicals’ influenza vaccine when administered in children who previously participated in study 115345EUCTR2012-001230-34-PLGlaxoSmithKline Biologicals452
进行中（未招募）
不适用
Immunogenicity and safety study of GlaxoSmithKline (GSK) Biologicals’ influenza vaccine when administered in children who previously participated in study 115345Healthy volunteers (Immunization against influenza A and B in children aged 18 to 47 months)MedDRA version: 14.1Level: LLTClassification code 10022002Term: Influenza A virus infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: LLTClassification code 10022001Term: Influenza (epidemic)System Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: LLTClassification code 10022003Term: Influenza B virus infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: PTClassification code 10022000Term: InfluenzaSystem Organ Class: 10021881 - Infections and infestationsEUCTR2012-001230-34-CZGlaxoSmithKline Biologicals452